Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Coherus Oncology (CHRS) Debt Ratio (2016 - 2025)

Coherus Oncology (CHRS) has disclosed Debt Ratio for 12 consecutive years, with 0.14 as the latest value for Q4 2025.

  • Quarterly Debt Ratio rose 27.84% to 0.14 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.14 through Dec 2025, up 27.84% year-over-year, with the annual reading at 0.14 for FY2025, 27.84% up from the prior year.
  • Debt Ratio hit 0.14 in Q4 2025 for Coherus Oncology, up from 0.07 in the prior quarter.
  • In the past five years, Debt Ratio ranged from a high of 0.61 in Q1 2023 to a low of 0.07 in Q2 2024.
  • Historically, Debt Ratio has averaged 0.24 across 5 years, with a median of 0.13 in 2024.
  • Biggest five-year swings in Debt Ratio: soared 359.28% in 2022 and later tumbled 87.06% in 2024.
  • Year by year, Debt Ratio stood at 0.11 in 2021, then skyrocketed by 359.28% to 0.51 in 2022, then dropped by 22.29% to 0.4 in 2023, then plummeted by 71.72% to 0.11 in 2024, then grew by 27.84% to 0.14 in 2025.
  • Business Quant data shows Debt Ratio for CHRS at 0.14 in Q4 2025, 0.07 in Q3 2025, and 0.08 in Q2 2025.